CAI
Caris Life Sciences, Inc.
There isn't enough reported data to score CAI yet.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
CAI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Strong |
CAI's revenue and balance sheet are currently healthy, and its profitability and cash flow are stable.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
CAI PE Valuation
CAI has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
CAI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
CAI has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
CAI Earnings Per Share
CAI and HIMS do not have enough comparable growth data to identify a winner.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
CAI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $275.4M | +27% |
| Q2 2026 | $263.7M | +45% |
| Q1 2026 | $216.2M | +79% |
| Q4 2025 | $292.9M | +125% |
| Q3 2025 | $216.8M | +113% |
| Q2 2025 | $181.4M | +81% |
| Q1 2025 | $120.9M | +50% |
| Q3 2021 | $100.8M | +28% |
CAI has the edge over HIMS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7% | -8 points |
| Q2 2026 | 10% | +20 points |
| Q1 2026 | 2.4% | +50 points |
| Q4 2025 | 30% | +59 points |
| Q3 2025 | 15% | +75 points |
| Q2 2025 | -9.9% | -77 points |
| Q1 2025 | -48% | +66 points |
| Q4 2024 | -29% | -94 points |
CAI has the edge over HIMS on profitability, with a higher operating margin.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS's revenue has grown year over year every quarter since late 2021: $890M last quarter, up 49% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
CAI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$39.7M | -172% |
| Q1 2026 | $22.5M | +$56.6M |
| Q4 2025 | $39.7M | +$80.9M |
| Q3 2025 | $55.3M | +$126.6M |
| Q1 2025 | -$34M | +$41.6M |
| Q3 2021 | -$447.6M | -895% |
| Q2 2021 | -$18.8M | -131% |
| Q1 2021 | -$95.9M | -397% |
CAI's free cash flow has turned positive after three years mostly in the red: $29M over the past year.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over CAI on cash generation, producing positive trailing cash flow while its opponent burns cash.
CAI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.3% | +12.3M shares |
| 1 year | +355% | +230M shares |
CAI has 295M diluted shares, up 355% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $10M |
| Q2 2026 | $21.4M |
| Q1 2026 | — |
| Q4 2025 | $91,000 |
| Q3 2025 | — |
| Q1 2025 | $22,000 |
| Q4 2024 | — |
| Q3 2024 | — |
CAI spent $31M buying back its own shares over the past year.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over CAI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
CAI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -3.4x | Net Cash |
| Q4 2025 | -11.6x | Net Cash |
| Q3 2021 | 7.5x | High |
| Q2 2021 | 6.5x | High |
| Q1 2021 | 6.2x | High |
| Q4 2020 | 6.7x | High |
| Q3 2020 | 9.6x | High |
| Q2 2020 | 8.5x | High |
CAI has more cash than debt.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has the edge over CAI on leverage, with a lower net debt burden relative to earnings.
CAI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 51.8 | Neutral |
CAI's weekly RSI is 48 (neutral) and its Stochastic is 52 (neutral).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
CAI PE vs Healthcare Sector
CAI has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
CAI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.5 | 19% below |
| 20 week MA | $24.7 | 3.2% below |
| 50 week MA | $22.5 | 6.7% above |
CAI has stronger trend alignment. CAI is above 1 of 3 weekly averages versus HIMS above 0 of 5.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
CAI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $27.3 | $28.2 | +3.6% |
| 2026 YTD | $28.2 | $24.0 | -15% |
CAI has the edge over HIMS on returns for 2026, with the stronger performance.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.